Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation

Circ Res. 2003 Jun 27;92(12):1314-21. doi: 10.1161/01.RES.0000079027.44309.53. Epub 2003 May 29.

Abstract

Proliferation of vascular smooth muscle cells (VSMCs) contributes to intimal thickening during atherosclerosis and restenosis. The cadherins are transmembrane proteins, which form cell-cell contacts and may regulate VSMC proliferation. In this study, N-cadherin protein concentration was significantly reduced by stimulation of proliferation with fetal calf serum (FCS) and platelet-derived growth factor-BB (PDGF-BB) in human saphenous vein VSMCs. Furthermore, overexpression of a truncated N-cadherin, which acts as a dominant-negative increased VSMC proliferation. The amount of an extracellular fragment of N-cadherin (approximately 90 kDa) in the media after 24 hours was increased by 12-fold by FCS and 11-fold by PDGF-BB, suggesting that N-cadherin levels are regulated by proteolytic shedding. Incubation with a synthetic metalloproteinase inhibitor or adenoviral overexpression of the endogenous tissue inhibitors of metalloproteinases (TIMPs) demonstrated that metalloproteinase activity was responsible in part for this proteolysis. Although total levels of beta-catenin protein were not affected, beta-catenin was translocated to the nucleus after stimulation with FCS and PDGF-BB. Our data indicates cadherin-mediated cell-cell contacts modulate proliferation in VSMCs. Furthermore, disruption of N-cadherin cell-cell contacts mediated in part by metalloproteinase activity occurs during VSMC proliferation, releasing beta-catenin and possibly inducing beta-catenin-mediated intracellular signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Cadherins / genetics
  • Cadherins / metabolism*
  • Cattle
  • Cell Adhesion / physiology
  • Cell Communication / physiology*
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cell Nucleus / metabolism
  • Culture Media / pharmacology
  • Cytoskeletal Proteins / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Fetal Blood
  • Gene Expression
  • Humans
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Mutation
  • Peptide Fragments / metabolism
  • Platelet-Derived Growth Factor / pharmacology
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-sis
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Trans-Activators / metabolism
  • Transfection
  • beta Catenin

Substances

  • CTNNB1 protein, human
  • Cadherins
  • Culture Media
  • Cytoskeletal Proteins
  • Peptide Fragments
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Tissue Inhibitor of Metalloproteinase-1
  • Trans-Activators
  • beta Catenin
  • Tissue Inhibitor of Metalloproteinase-2
  • Becaplermin